Published in Kidney Int on April 25, 2007
Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol (2009) 1.58
Serum resistin and glomerular filtration rate in patients with type 2 diabetes. PLoS One (2015) 1.41
Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism. Cardiovasc Diabetol (2014) 1.08
The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis (2010) 1.05
Adiponectin action: a combination of endocrine and autocrine/paracrine effects. Front Endocrinol (Lausanne) (2011) 0.95
Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis (2010) 0.94
Circulating adipocytokines and chronic kidney disease. PLoS One (2013) 0.89
Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes (2008) 0.87
Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study. PLoS One (2013) 0.86
Adiponectin and renal disease progression: another epidemiologic conundrum? Kidney Int (2007) 0.84
Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II. Physiol Rep (2014) 0.82
Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants. Eur J Epidemiol (2014) 0.81
Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes. Sci Rep (2015) 0.81
Serum adiponectin levels and mortality after kidney transplantation. Clin J Am Soc Nephrol (2012) 0.80
Relationship between plasma adiponectin level with inflammatory and metabolic markers in patients with chronic kidney disease. Nephrourol Mon (2013) 0.80
Adiponectin, cardiovascular disease, chronic kidney disease: emerging data on complex interactions. Pediatr Nephrol (2011) 0.79
Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in asian adults. PLoS One (2015) 0.78
Proteinuria and its relation to diverse biomarkers and body mass index in chronic hemodialysis. Int J Nephrol Renovasc Dis (2013) 0.78
Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability. Dis Markers (2015) 0.77
Adipokines protecting CKD. Nephrol Dial Transplant (2013) 0.77
The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients. PLoS One (2012) 0.77
The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study. HIV Med (2014) 0.75
Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study. Diabetol Metab Syndr (2016) 0.75
Subattomole detection of adiponectin in urine by ultrasensitive ELISA coupled with thio-NAD cycling. Biophys Physicobiol (2015) 0.75
Adiponectin in children and young adults with focal segmental glomerulosclerosis. Pediatr Nephrol (2015) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol (2007) 4.59
The nephrotic syndrome. N Engl J Med (1998) 3.22
Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98
Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42
Hantavirus infection presenting as acute renal failure. Lancet (1990) 2.40
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant (2000) 2.38
Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol (1998) 2.24
Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus. J Clin Endocrinol Metab (2006) 2.12
The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. Nephrol Dial Transplant (1995) 2.06
Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest (1989) 1.98
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int (1998) 1.77
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol (2005) 1.74
Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant (1998) 1.71
In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int (2007) 1.61
Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig (1992) 1.61
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int (1998) 1.61
Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost (1984) 1.59
Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant (1995) 1.54
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. Eur J Clin Invest (2003) 1.49
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int (2001) 1.49
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48
Right-sided chest pain at the onset of haemodialysis. Nephrol Dial Transplant (2001) 1.44
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Perit Dial Int (1996) 1.42
Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. Nephron (1994) 1.42
The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. Nephrol Dial Transplant (1992) 1.41
Parathyroidectomy in secondary (renal) hyperparathyroidism--whom, when, how? Int J Artif Organs (1993) 1.41
[Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. Dtsch Med Wochenschr (1995) 1.40
Horseshoe kidney. Nephrol Dial Transplant (1999) 1.40
[Calculated renal function: benefits and problems of the "Modification of Diet in Renal Disease" (MDRD) formula]. Dtsch Med Wochenschr (2005) 1.39
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
[Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. Dtsch Med Wochenschr (2003) 1.39
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. Dtsch Med Wochenschr (2004) 1.39
Type II diabetes mellitus: is the renal risk adequately appreciated? Nephrol Dial Transplant (1991) 1.39
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant (1991) 1.38
[The quality of the treatment of diabetics in kidney failure in Germany]. Dtsch Med Wochenschr (2000) 1.38
Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats. Eur J Clin Invest (1999) 1.38
Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38
Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) Eur J Clin Invest (1989) 1.38
Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol (1998) 1.37
The Normal Haematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin? Nephrol Dial Transplant (1998) 1.36
Use of complementary and alternative medicine among women in New York City: a pilot study. J Altern Complement Med (2001) 1.36
Bone histology in incipient and advanced renal failure. Kidney Int (1976) 1.35
Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr (1974) 1.34
Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int (1999) 1.33
Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int (1998) 1.32
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol (2000) 1.32
Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant (1992) 1.30
Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant (1990) 1.30
Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet (2005) 1.29
1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood (1993) 1.28
Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance. Kidney Int (1988) 1.27
Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int (1997) 1.27
Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int (1998) 1.26
Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney Int (2008) 1.26
Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol (2008) 1.25
Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int (1987) 1.24
Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol (1993) 1.24
Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol (2000) 1.24
Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol (1991) 1.23
Acquired renal cysts in uremic patients--in vivo demonstration by computed tomography. Clin Nephrol (1980) 1.22
Necrotizing dermatitis resulting from hemodialysis with polyvinylchloride tubing. Ann Intern Med (1979) 1.21
Is vasculitis in subacute bacterial endocarditis associated with ANCA? Lancet (1991) 1.20
Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol (1984) 1.20
Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol (1996) 1.20
Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol (2000) 1.20
Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant (1998) 1.19
Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int (1973) 1.18
Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol (1988) 1.17
Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant (1989) 1.17
A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol (1994) 1.17
1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int (1989) 1.16
Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. Q J Med (1970) 1.15
Thermoregulatory physiology of menopausal hot flashes: a review. Can J Physiol Pharmacol (1987) 1.15
Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev (2007) 1.15
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia (2003) 1.14
Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int (1999) 1.14
Lack of expression of differentiation in mouse teratoma-fibroblast somatic cell hybrids. Exp Cell Res (1973) 1.14
Reduced capillary density in the myocardium of uremic rats--a stereological study. Kidney Int (1992) 1.12
Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens (2000) 1.12
Beta blockers in the management of chronic kidney disease. Kidney Int (2006) 1.11
Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1993) 1.11
Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int (1987) 1.11
No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest (1997) 1.10
Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant (1989) 1.10
The renal risks of smoking. Kidney Int (1997) 1.10
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol (1996) 1.10
Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int (1995) 1.09
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol (2000) 1.09
Use of complementary and alternative medicine among African-American and Hispanic women in New York City: a pilot study. J Am Med Womens Assoc (1999) 1.08
Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int (1997) 1.08
Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol (2001) 1.08